[1] | World Health Organization. Control of the leishmaniasis[R]. Geneva: WHO, 2010: 5-12. | [2] | Al-Salem W, Herricks JR, Hotez PJ. A review of visceral leishmaniasis during the conflict in South Sudan and the consequences for East African countries[J]. Parasit Vectors, 2016, 9(1): 460. | [3] | World Health Organization. Leishmaniasis[EB/OL]. (2023-01-12)[2024-09-25]. http://www.who.int/news-room/fact-sheets/detail/leishmaniasis. | [4] | Casulli A. New global targets for NTDs in the WHO roadmap 2021-2030[J]. PLoS Negl Trop Dis, 2021, 15(5): e0009373. | [5] | Wang ZJ, Wu ZJ. Kala-azar[M]. Beijing: People’s Medical Publishing House, 1956: 433-609. (in Chinese) | | (王兆俊, 吴征鉴. 黑热病学[M]. 北京: 人民卫生出版社, 1956: 433-609.) | [6] | Wang ZJ, Xiong GH, Guan LR. Epidemiology and control achievements of kala-azar in new China[J]. Chin J Epidemiol, 2000, 21(1): 51-54. (in Chinese) | | (王兆俊, 熊光华, 管立人. 新中国黑热病流行病学与防治成就[J]. 中华流行病学杂志, 2000, 21(1): 51-54.) | [7] | Zhao YZ, Jiang D, Ding FY, et al. Recurrence and driving factors of visceral leishmaniasis in Central China[J]. Int J Environ Res Public Health, 2021, 18(18): 9535. | [8] | Zhou ZB, Pan GQ, Li YY, et al. Prevalence of visceral leishmaniasis in China in 2021[J]. Chin J Parasitol Parasit Dis, 2023, 41(2): 149-155. (in Chinese) | | (周正斌, 潘改芹, 李元元, 等. 2021年我国内脏利什曼病疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(2): 149-155.) | [9] | Li YY, Zhou ZB, Yang LM, et al. Epidemiological characteristics of visceral leishmaniasis in China in 2022[J]. Chin J Parasitol Parasit Dis, 2023, 41(6): 669-676. (in Chinese) | | (李元元, 周正斌, 杨丽敏, 等. 2022年全国内脏利什曼病疫情特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(6): 669-676.) | [10] | Guan LR. Recent advances in visceral leishmaniasis in China[J]. Southeast Asian J Trop Med Pub Health, 1991, 22(3): 291-298. | [11] | Hao YW, Hu XK, Gong YF, et al. Spatio-temporal clustering of mountain-type zoonotic visceral leishmaniasis in China between 2015 and 2019[J]. PLoS Negl Trop Dis, 2021, 15(3): e0009152. | [12] | Zhou Z, Lyu S, Zhang Y, et al. Visceral leishmaniasis-China, 2015-2019[J]. China CDC Wkly, 2020, 2(33): 625-628. | [13] | Chai JJ. Leishmaniasis and phlebotomine sandflies in the Xinjiang Uygur Autonomous Region the People’s Republic of China[M]. Urumqi: Xijiang People’s Publishing House, 2006: 293-348. (in Chinese) | | (柴君杰. 新疆维吾尔自治区的利什曼病与白蛉[M]. 乌鲁木齐: 新疆人民出版社, 2006: 293-348.) | [14] | Saha P, Ganguly S, Chatterjee M, et al. Asymptomatic leishmaniasis in kala-azar endemic areas of Malda District, West Bengal, India[J]. PLoS Negl Trop Dis, 2017, 11(2): e0005391. | [15] | Wang JY, Cui G, Chen HT, et al. Current epidemiological profile and features of visceral leishmaniasis in people’s republic of China[J]. Parasit Vectors, 2012, 5: 31. | [16] | Luo ZW, Zhou ZB, Gong YF, et al. Current status and challenges of visceral leishmaniasis in China[J]. Chin J Parasitol Parasit Dis, 2022, 40(2): 146-152. (in Chinese) | | (罗卓韦, 周正斌, 公衍峰, 等. 我国内脏利什曼病的流行现状和防控挑战[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(2): 146-152.) | [17] | Zhang PJ, Zhou ZB, Li YY, et al. Prevalence of mountain-zoonotic type visceral leishmaniasis in Yangquan City of Shanxi Province from 2015 to 2020[J]. Chin J Schisto Control, 2022, 34(5): 493-499. (in Chinese) | | (张佩君, 周正斌, 李元元, 等. 2015—2020年山西省阳泉市犬源型内脏利什曼病疫情调查[J]. 中国血吸虫病防治杂志, 2022, 34(5): 493-499.) | [18] | Ribas LM, Zaher VL, Shimozako HJ, et al. Estimating the optimal control of zoonotic visceral leishmaniasis by the use of a mathematical model[J]. Sci World J, 2013, 2013: 810380. | [19] | Courtenay O, Quinnell RJ, Garcez LM, et al. Infectiousness in a cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission[J]. J Infect Dis, 2002, 186(9): 1314-1320. | [20] | Otranto D, Dantas-Torres F, de Caprariis D, et al. Prevention of canine leishmaniosis in a hyper-endemic area using a combination of 10% imidacloprid/4.5% flumethrin[J]. PLoS One, 2013, 8(2): e56374. | [21] | Mazloumi Gavgani AS, Hodjati MH, Mohite H, et al. Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial[J]. Lancet, 2002, 360(9330): 374-379. | [22] | Montenegro Qui?onez CA, Runge-Ranzinger S, Rahman KM, et al. Effectiveness of vector control methods for the control of cutaneous and visceral leishmaniasis: a meta-review[J]. PLoS Negl Trop Dis, 2021, 15(5): e0009309. | [23] | World Health Organization. Public notice and comments on the guideline development group (GDG) for leishmaniasis vector and reservoir control[EB/OL]. (2024-03-12)[2024-09-25]. https://www.who.int/news-room/articles-detail/public-notice-and-comments-on-the-guideline-development-group-for-leishmaniasis-vector-and-reservoir-control. |
|